Skip to main content
Premium Trial:

Request an Annual Quote

Headed Back to Court

Lawyers for the American Civil Liberties Union and Myriad Genetics headed back to court last Friday to argue about whether isolated DNA is a product of nature or whether it is eligible to be patented, reports Bloomberg Businessweek. The lawyers appeared before the US Court of Appeals for the Federal Circuit to make their cases; the Supreme Court ordered the appeals court to re-hear the case involved patents on the breast cancer genes BRCA1 and BRCA2 after the Prometheus v. Mayo decision that also dealt with patents. Last year, the court ruled in favor of Myriad's claim that isolated DNA could be patented.

"We need to be sure that natural things and all natural laws are available to all mankind," said Chris Hansen, a lawyer for the ACLU, according to Bloomberg Businessweek. The Myriad claims "cover every conceivable form of DNA," he added.

Myriad lawyer Greg Castanias of Jones Day disagreed. "The patent claims reflect not naturally occurring, but human-made compositions that were the product of human ingenuity," he said. "This is not the patenting of a natural product or something so close to a natural product that it can't be patented."

Daily Scan's sister publication Pharmacogenomics Reporter has more on the arguments here.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.